MEDIS IN THE NEWS

November 21, 2007

Medis Fuel Cell Production Boosts Celestica in Galway, Ireland

LONDON — 11/21/2007 7:56 AM EST
EETIMES reports that Celestica has expanded the automated manufacturing services (AMS) capability in Ireland with the creation of 120 jobs covering quality, engineering, automation and chemistry as well as production.The expansion of Celestica's Galway facility will enable the company to manufacture a fuel cell power pack for its New York-based customer, Medis Technologies Ltd (NASDAQ:MDTL).

The Medis Power Pack has enough power to drive many handheld devices when the battery is nearly depleted and it will also function as a portable charger. The 24-7 Power Pack provides sufficient energy to provide up to 30 hours of talk time to an average mobile phone or 60-80 hours of play time for an average iPod. The power is sufficient (1 watt)) to operate, and charge, multiple times, a range of the standard and advanced portable electronic devices.
Minister Martin said "This is superb news for Celestica and indeed Galway as it represents yet another example of how the West of Ireland can attract and support the most sophisticated and leading edge investment.

"The level of automation in this project is exceptional and signals a very positive direction in Irish-based manufacturing towards state-of-the-art automation which requires a skilled workforce to operate and maintain,"said Micheál Martin TD, Minister for Enterprise, Trade and Employment.

The facility was previously owned by Manufacturers Services Ltd (MSL) and was established in Galway in 2000. In 2004 Celestica acquired MSL and became Celestica Ireland Ltd. The facility employs 380 people.

CLICK HERE FOR ARTICLE IN EETIMES


 

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called “forward looking statements” by words such as “may,” “will,” “should,” “expects,” plans,” “targets,” “believes,” “anticipates,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.

CONTACT:
Medis Technologies Ltd.
Robert K. Lifton
Chairman & CEO
212-935-8484
or
INVESTOR RELATIONS COUNSEL:
The Equity Group Inc.
Adam Prior
212-836-9606

 



About Us
About UsInvestor RelationsProductsTechnologiesContact Us

bulletOverview
bulletPeople
bulletFacilities
bulletRecent News
bulletQuality Policy
bulletCareers

Copyright © 2008 Medis Technologies. All rights reserved